Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Tegsedi (Inotersen) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Tegsedi Covered by Blue Cross Blue Shield in New Jersey Tegsedi (inotersen) requires prior authorization from Blue Cross Blue Shield plans in New Jersey, typically as a non-preferred specialty drug. To get coverage: (1) Your neurologist submits a PA request with hATTR polyneuropathy diagnosis, genetic testing, and

Blue Cross Blue Shield Michigan's Coverage Criteria for Pyrukynd (mitapivat): What Counts as "Medically Necessary"?

Answer Box: Getting Pyrukynd Covered in Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Pyrukynd (mitapivat), typically with these three key steps: (1) Confirmed PKLR gene variants proving pyruvate kinase deficiency, (2) Clinical severity documentation (hemoglobin ≤10 g/dL or ≥6 transfusions in 12 months), and (3)

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Appeals Guide

Answer Box: Getting Helixate Covered in Pennsylvania Important Update: Helixate NexGen and related Kogenate FS have been discontinued by Bayer. Blue Cross Blue Shield Pennsylvania plans now require prior authorization for alternative factor VIII products like Kovaltry, Advate, or Jivi. The fastest path to approval: (1) Have your hematologist submit

The Requirements Checklist to Get Raxone (Idebenone) Covered by Blue Cross Blue Shield of Illinois

Answer Box Getting Raxone (idebenone) covered by Blue Cross Blue Shield of Illinois requires a formulary exception plus prior authorization since it's not FDA-approved in the U.S. Your fastest path: (1) Have your prescriber submit a pharmacy PA request through MyPrime with genetic testing confirming LHON and

How to Get Vigabatrin (Sabril) Covered by Blue Cross Blue Shield in Illinois: Complete REMS Guide and Appeal Process

Quick Answer: Blue Cross Blue Shield Illinois requires prior authorization for vigabatrin (Sabril), complete REMS enrollment, and vision monitoring documentation. Start the PA process 30-45 days before your current authorization expires. If denied, you have 60 days to file an internal appeal, then 30 days for external review through the

How to Get Elevidys Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide with Appeals Process

Answer Box: To get Elevidys covered by Blue Cross Blue Shield in Pennsylvania, you need: 1) Confirmed DMD genetic testing showing pathogenic mutation, 2) Age ≥4 years with negative anti-AAVrh74 antibodies, 3) Prior authorization through your BCBS plan's electronic portal (Availity for Highmark, IBX portal for Independence). Most

How to Get Lamzede (velmanase alfa-tycv) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide

Quick Answer: Blue Cross Blue Shield requires prior authorization for Lamzede (velmanase alfa-tycv) in Pennsylvania. You'll need confirmed alpha-mannosidosis diagnosis with enzyme activity below 11% of normal, documentation of non-CNS manifestations, and agreement to monitor for infusion reactions. If denied, Pennsylvania's new external review program overturns

Do You Qualify for Prolastin-C Coverage by Blue Cross Blue Shield in Georgia? Decision Tree & Next Steps

Answer Box: Getting Prolastin-C Covered in Georgia Most likely to get approved: Adults with confirmed severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype, AAT level ≤11 µM), emphysema on imaging, non-smoking status, and documented optimal COPD therapy. Blue Cross Blue Shield Georgia typically requires prior authorization through their specialty pharmacy program.

How to Get Brensocatib (BRINSUPRI) Covered by Blue Cross Blue Shield in Florida: Complete Appeals Guide

Answer Box: Getting Brensocatib (BRINSUPRI) Covered by Blue Cross Blue Shield in Florida Fastest Path: 1) Check if BRINSUPRI is on your Florida Blue formulary via their Drug Search tool. 2) If not listed or requires PA, submit prior authorization with documented macrolide failure/contraindication and ≥2 exacerbations/year. 3)

Renewing Soliris (Eculizumab) Coverage with Blue Cross Blue Shield in North Carolina: Complete Timeline and Documentation Guide

Answer Box: Soliris (eculizumab) requires annual reauthorization with Blue Cross Blue Shield of North Carolina. Start renewal 30-60 days before expiration by gathering updated labs (LDH, hemoglobin, platelets), clinical response documentation, and current vaccination records. Submit through Blue e or your specialty pharmacy. If denied, use Smart NC external review—